Two Sigma Advisers’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-73
| Closed | -$152K | – | 2653 |
|
|
2022
Q1 | $152K | Sell |
73
-92
| -56% | -$192K | ﹤0.01% | 2430 |
|
|
2021
Q4 | $806K | Sell |
165
-113
| -41% | -$552K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $1.75M | Sell |
278
-146
| -34% | -$917K | ﹤0.01% | 1328 |
|
|
2021
Q2 | $4M | Buy |
424
+284
| +203% | +$2.68M | 0.01% | 962 |
|
|
2021
Q1 | $1.22M | Buy |
140
+10
| +8% | +$87K | ﹤0.01% | 1547 |
|
|
2020
Q4 | $986K | Sell |
130
-31
| -19% | -$235K | ﹤0.01% | 1574 |
|
|
2020
Q3 | $1.05M | Buy |
161
+137
| +571% | +$897K | ﹤0.01% | 1483 |
|
|
2020
Q2 | $179K | Buy |
+24
| New | +$179K | ﹤0.01% | 2274 |
|